These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
198 related items for PubMed ID: 19032129
21. Human aqueous humor concentrations of besifloxacin, moxifloxacin, and gatifloxacin after topical ocular application. Donnenfeld ED, Comstock TL, Proksch JW. J Cataract Refract Surg; 2011 Jun; 37(6):1082-9. PubMed ID: 21596251 [Abstract] [Full Text] [Related]
22. Aqueous humor concentrations of topical fluoroquinolones alone or in combination with a steroid. Gomes RLR, Viana RG, Melo LAS, Cruz AC, Lima AAS, Suenaga EM, Campos M. Arq Bras Oftalmol; 2017 Jun; 80(5):300-303. PubMed ID: 29160540 [Abstract] [Full Text] [Related]
23. Treatment of experimental bacterial keratitis with topical trovafloxacin. Barequet IS, Denton P, Osterhout GJ, Tuli S, O'Brien TP. Arch Ophthalmol; 2004 Jan; 122(1):65-9. PubMed ID: 14718297 [Abstract] [Full Text] [Related]
24. A comparison of fluoroquinolone penetration into human conjunctival tissue. Aihara M, Miyanaga M, Minami K, Miyata K, Eguchi S, Shiroma H, Sawaguchi S. J Ocul Pharmacol Ther; 2008 Dec; 24(6):587-91. PubMed ID: 19049265 [Abstract] [Full Text] [Related]
25. Effect of diclofenac on ocular levels of ciprofloxacin and lomefloxacin in rabbits with endophthalmitis. Krustev SZ, Rusenova NV, Haritova AM. Drug Dev Ind Pharm; 2014 Nov; 40(11):1459-62. PubMed ID: 23937580 [Abstract] [Full Text] [Related]
26. The antibacterial activity of levofloxacin eye drops against staphylococci using an in vitro pharmacokinetic model in the bulbar conjunctiva. Suzuki T, Yamamoto T, Ohashi Y. J Infect Chemother; 2016 Jun; 22(6):360-5. PubMed ID: 27036073 [Abstract] [Full Text] [Related]
27. Comparison of moxifloxacin and levofloxacin in an epithelial disorder model using cultured rabbit corneal epithelial cell sheets. Miyake T, Ito N, Tajima K, Goto H, Furukawa T. Graefes Arch Clin Exp Ophthalmol; 2012 Jul; 250(7):1035-41. PubMed ID: 22282216 [Abstract] [Full Text] [Related]
28. In vitro efficacy and pharmacodynamic indices for antibiotics against coagulase-negative staphylococcus endophthalmitis isolates. Harper T, Miller D, Flynn HW. Ophthalmology; 2007 May; 114(5):871-5. PubMed ID: 17383732 [Abstract] [Full Text] [Related]
29. Penetration pharmacokinetics of topically administered 0.5% moxifloxacin ophthalmic solution in human aqueous and vitreous. Hariprasad SM, Blinder KJ, Shah GK, Apte RS, Rosenblatt B, Holekamp NM, Thomas MA, Mieler WF, Chi J, Prince RA. Arch Ophthalmol; 2005 Jan; 123(1):39-44. PubMed ID: 15642810 [Abstract] [Full Text] [Related]
30. Penetration of gatifloxacin eye drops into the aqueous humor in humans. Teshigawara T, Hata S, Hayashi T, Watanabe Y, Itoh Y, Hitoi K, Mizuki N. Ocul Immunol Inflamm; 2007 Jan; 15(4):309-13. PubMed ID: 17763128 [Abstract] [Full Text] [Related]
31. In Vitro Antimicrobial Activity of Quinolones Against Major Bacterial Isolates from the Ocular Surface Bacterial Flora of Tertiary Hospital Patients in Japan. Eguchi H, Nishida K, Hotta F, Shimomura Y, Kusaka S. J Ocul Pharmacol Ther; 2021 Mar; 37(2):84-89. PubMed ID: 33395563 [Abstract] [Full Text] [Related]
32. Comparative penetration of moxifloxacin and gatifloxacin in rabbit aqueous humor after topical dosing. Levine JM, Noecker RJ, Lane LC, Herrygers L, Nix D, Snyder RW. J Cataract Refract Surg; 2004 Oct; 30(10):2177-82. PubMed ID: 15474833 [Abstract] [Full Text] [Related]
33. Ocular penetration and pharmacokinetics of topical gatifloxacin 0.3% and moxifloxacin 0.5% ophthalmic solutions after keratoplasty. Holland EJ, Lane SS, Kim T, Raizman M, Dunn S. Cornea; 2008 Apr; 27(3):314-9. PubMed ID: 18362660 [Abstract] [Full Text] [Related]
34. Ocular distribution of difluprednate ophthalmic emulsion 0.05% in rabbits. Tajika T, Isowaki A, Sakaki H. J Ocul Pharmacol Ther; 2011 Feb; 27(1):43-9. PubMed ID: 21118027 [Abstract] [Full Text] [Related]
35. Comparative Study Between Topical Gatifloxacin 0.5% and Moxifloxacin 0.5% as a Prophylactic Measure Before Intraocular Surgery. Abdel-Meguid AAE, Gabr AF, Said MM, Nassef MAEH, Elmenofy TMI. J Ocul Pharmacol Ther; 2019 Jun; 35(5):315-318. PubMed ID: 30950680 [Abstract] [Full Text] [Related]
36. Aqueous Humor Penetration and Biological Activity of Moxifloxacin 0.5% Ophthalmic Solution Alone or with Dexamethasone 0.1. Gomes RL, Viana RG, Melo LA, Cruz AC, Suenaga EM, Kenyon KR, Campos M. J Ocul Pharmacol Ther; 2017 Mar; 33(2):98-102. PubMed ID: 28231036 [Abstract] [Full Text] [Related]
37. Aqueous penetration of gatifloxacin and levofloxacin into the rabbit aqueous humor following topical dosing. Levine JM, Noecker RJ, Lane LC, Snyder RW, Rapedius M, Blanchard J. J Ocul Pharmacol Ther; 2004 Jun; 20(3):210-6. PubMed ID: 15279726 [Abstract] [Full Text] [Related]
38. [Antibacterial activity of quinolones against various clinically isolated strains and evaluation of efficacy based on the pharmacokinetics/pharmacodynamics theory]. Nakamura T, Shimizu C, Hirakawa K, Inui S, Okuda K, Nakata C, Fujimoto H, Okura H, Uemura Y, Takahashi H. Jpn J Antibiot; 2009 Jun; 62(3):194-202. PubMed ID: 19882980 [Abstract] [Full Text] [Related]
39. Ocular pharmacokinetics profile of different indomethacin topical formulations. Bucolo C, Melilli B, Piazza C, Zurria M, Drago F. J Ocul Pharmacol Ther; 2011 Dec; 27(6):571-6. PubMed ID: 22059858 [Abstract] [Full Text] [Related]
40. Aqueous penetration of moxifloxacin 0.5% ophthalmic solution and besifloxacin 0.6% ophthalmic suspension in cataract surgery patients. Yoshida J, Kim A, Pratzer KA, Stark WJ. J Cataract Refract Surg; 2010 Sep; 36(9):1499-502. PubMed ID: 20692561 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]